- C
Charcot-Marie-Tooth Association
- Gilles Bouchard
Gilles Bouchard serves as the Chairman of the Board for the Charcot-Marie-Tooth Association since March 2016, focusing on supporting drug development and improving quality of life for individuals with CMT. As the Founder of Bouchard & Associates since 2016, Gilles has also held prominent leadership roles such as Chairman and CEO at Livescribe Inc. (2011-2015) and President and CEO at Opnext (2007-2010). Prior to these positions, extensive experience was gained during a significant tenure at HP from 1989 to 2007, where roles included EVP of Global Operations and CIO. Additionally, experience began at IBM Watson Research Center as a Member of Research Staff (1984-1988). Educational credentials include Executive Education from Harvard Business School and INSEAD, a Master of Science in Engineering from the University of California, Berkeley, and a Diplôme d'Ingénieur from Centrale Lyon.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Charcot-Marie-Tooth Association
Mission Our mission is to generate the resources to find a cure, to create awareness, and to improve the quality of life for those affected by Charcot-Marie-Tooth. The time is now: Our vision is a world without CMT! Description Charcot-Marie-Tooth, or CMT, is the most commonly inherited peripheral neuropathy and is found worldwide among all races and ethnic groups. Discovered in 1886 by three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth, CMT affects an estimated 2.8 million people. General Information The CMTA is a 501(C)(3)nonprofit organization founded in 1983 whose goals are patient support, public education, promotion of research and ultimately the treatment and cure of CMT. A voluntary Board of Directors governs the CMTA. The Medical Advisory Board of the CMTA consists of over 50 clinical and research medical professionals. This international group of men and women are noted CMT experts in neurology, genetics, orthopedic surgery, physiatry, physical therapy and podiatry. The CMTA currently has more than 20,000 patients and families, supportive friends, and medical professionals in its database.
